Patent Assignment
Reel/Frame 054749/0588
Corrective Assignment to Correct the Proerty Numbers Data Previously Recorded at Reel: 054278 Frame: 0413. Assignor(S) Hereby Confirms the Assignment .
Recorded: 2020-12-14
Pages: 63
Assignor
VOLANT HOLDINGS, GMBH
Executed: 2020-11-02
Assignee
SAPIENZA RESEARCH, LLC
1116 W. FARM, SARATOGA, WYOMING, 82331
Covered Properties
(21)
Compositions and Methods for Inducing Satiety and Treating Non-Insulin Dependent Diabetes Emillitus, Pre-Diabetic Symptoms, Insulin Resistance and Related Disease States and Conditions
PCT:
PCT/US2009/005016 ↗
Activation of the Endogenous Ileal Brake Hormone Pathway for Organ Regeneration and Related Compositions, Methods of Treatment, Diagnostics, and Regulatory Systems
PCT:
PCT/US2015/040879 ↗
Method and Apparatus for Compensating Signal Distortion Caused by Noise
Compositions and Methods for Treating Insulin Resistance and Non-Insulin Dependent Diabetes Mellitus (Type Ii Diabetes)
Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hpperlipidemia, and type 2 diabetes
Application:
13/460,753 →
Publication:
US 2013/0273154
Compositions, Methods of Treatment and Diagnostics for Treatment of Hepatic Steatosis Alone or in Combination with a Hepatitis C Virus Infection
Oral formulations mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, methods of treatment, diagnostics and systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2D
Application:
14/354,744 →
Publication:
US 2014/0294951
Activation of the Endogenous Ileal Brake Hormone Pathway for Organ Regeneration and Related Compositions, Methods of Treatment, Diagnostics, and Regulatory Systems
Application:
14/759,283 →
Publication:
US 2015/0352189
Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and type 2 diabetes.
Application:
15/151,358 →
Publication:
US 2017/0014436
Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hyperlipidemia, and T2D
Application:
15/151,400 →
Publication:
US 2017/0007631
Compositions, Methods of Treatment and Diagnostics for Treatment of Hepatic Steatosis Alone or in Combination with a Hepatitis C Virus Infection
Activation of the Endogenous Ileal Brake Hormone Pathway for Organ Regeneration and Related Compositions, Methods of Treatment, Diagnostics, and Regulatory Systems
Application:
15/407,394 →
Publication:
US 2017/0173060
Diagnostics and Methods for Treatment of Non-Alcoholic Hepatic Steatosis and Hepatic Steatohepatitis, and Prevention of Complications Thereof
Application:
15/601,497 →
Publication:
US 2018/0099001
Compositions and Methods for Inducing Satiety and Treating Non-Insulin Dependent Diabetes Mellitus, Pre-Diabetic Symptoms, Insulin Resistance and Related Disease States and Conditions
Application:
15/623,734 →
Publication:
US 2018/0369177
Compositions, Methods of Treatment and Diagnostics for Treatment of Hepatic Steatosis Alone or in Combination with a Hepatitis C Virus Infection
Oral Formulations Mimetic of Roux-En-Y Gastric Bypass Actions on the Ileal Brake; Compositions, Methods of Treatment, Diagnostics and Systems for Treatment of Metabolic Syndrome Manifestations Including Insulin Resistance, Fatty Liver Disease, Hyperlipidemia, and Type 2 Diabetes
Application:
15/833,360 →
Oral Formulations Mimetic of Roux-En-Y Gastric Bypass Actions on the Ileal Brake; Compositions, Methods of Treatment, Diagnostics and Systems for Treatment of Metabolic Syndrome Manifestations Including Insulin Resistance, Fatty Liver Disease, Hyperlipidemia, and Type 2 Diabetes
Application:
16/059,199 →
Publication:
US 2019/0262367
Diagnostics and Methods for Treatment of Non-Alcoholic Hepatic Steatosis and Hepatic Steatohepatitis, and Prevention of Complications Thereof
Activation of the Endogenous Ileal Brake Hormone Pathway for Organ Regeneration and Related Compositions, Methods of Treatment, Diagnostics, and Regulatory Systems
Application:
16/167,892 →
Publication:
US 2019/0298804
Compositions and methods for inducing satiety
Application:
61/190,818 →
Compositions and Methods for Inducing Satiety and Treating Non-Insulin Dependent Diabetes Emllitus, Pre-Diabetic Symptoms, Insulin Resistance and Related Disease States and Conditions
Application:
61/309,991 →
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 6, 2008
From: KIM, IL-DO; JUN, JAE-SUNG; CHOI, BYUNG-SUN
To: SAMSUNG ELECTRONICS CO., LTD.
Reel/Frame 020469/0353 →
Assignment of Assignor's Interest
Mar 3, 2009
From: FAYAD, JOSEPH
To: NEW SCIENCE HOLDINGS LLC
Reel/Frame 022339/0245 →
Assignment of Assignor's Interest
Apr 19, 2010
From: FAYAD, JOSEPH
To: NEW SCIENCE HOLDINGS, LLC
Reel/Frame 024253/0790 →
Assignment of Assignor's Interest
Sep 23, 2015
From: SCHENTAG, JEROME J.
To: THERABRAKE, INC.
Reel/Frame 036635/0983 →
Assignment of Assignor's Interest
Sep 23, 2015
From: SCHENTAG, JEROME J.
To: THERABRAKE, INC.
Reel/Frame 036635/0827 →
Assignment of Assignor's Interest
Sep 23, 2015
From: THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK
To: SCHENTAG, JEROME; MONTE, SCOTT V.
Reel/Frame 036637/0840 →
Assignment of Assignor's Interest
Sep 23, 2015
From: FAYAD, JOSEPH M., M.D.
To: THERABRAKE, INC.
Reel/Frame 036637/0792 →
Assignment of Assignor's Interest
Nov 13, 2015
From: THERABRAKE, INC.
To: VOLANT HOLDINGS GMBH
Reel/Frame 037031/0980 →
Lien
Sep 11, 2017
From: COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
To: VOLANT HOLDINGS GMBH; THERABRAKE, INC.
Reel/Frame 043811/0240 →
Corrective Assignment to Pct Number PCTUS2014040879 to PCTUS2015040879 Previously Recorded on Reel 043811 Frame 0240. Assignor(S) Hereby Confirms the Lien.
Oct 10, 2017
From: COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
To: VOLANT HOLDINGS GMBH; THERABRAKE, INC.
Reel/Frame 044625/0718 →
Assignment of Assignor's Interest
Feb 20, 2020
From: SCHENTAG, JEROME; FAYAD, JOSEPH M.
To: VOLANT HOLDINGS GMBH
Reel/Frame 051869/0402 →
Intellectual Property Assignment Agreement, Effective August 28, 2008 and Judgment+Ruling
Apr 28, 2020
From: FAYAD, JOSEPH, M.D.
To: NEW SCIENCE HOLDINGS, LLC
Reel/Frame 052515/0347 →
Assignment of Assignor's Interest
May 5, 2020
From: FAYAD, JOSEPH
To: NEW SCIENCE HOLDINGS, LLC
Reel/Frame 052571/0903 →
Intellectual Property Assignment Agreement, Effective August 28, 2008 and Judgment+Ruling
May 5, 2020
From: FAYAD, JOSEPH, M.D.
To: NEW SCIENCE HOLDINGS, LLC
Reel/Frame 052681/0518 →
Assignment of Assignor's Interest
Nov 2, 2020
From: VOLANT HOLDINGS, GMBH
To: SAPIENZA RESEARCH, LLC
Reel/Frame 054278/0413 →
Court Order
Sep 23, 2022
From: UNITED STATES DISTRICT COURT-SOUTHERN DISTRICT OF NY
To: COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
Reel/Frame 061535/0328 →
Court Order
Sep 29, 2022
From: UNITED STATES DISTRICT COURT S. DISTRICT OF NEW YORK
To: JEROME SCHENTAG & THERABRAKE, INC.
Reel/Frame 061569/0496 →
Assignment of Assignor's Interest
Mar 13, 2023
From: FAYAD, JOSEPH
To: NEW SCIENCE HOLDINGS LLC
Reel/Frame 063590/0665 →
Assignment of Assignor's Interest
Mar 13, 2023
From: FAYAD, JOSEPH
To: NEW SCIENCE HOLDINGS LLC
Reel/Frame 063661/0721 →
Assignment of Assignor's Interest
Sep 19, 2023
From: NEW SCIENCE HOLDINGS, LLC
To: APHAIA IP AG
Reel/Frame 064955/0189 →
Assignment of Assignor's Interest
Dec 16, 2024
From: SAPIENZA RESEARCH, LLC
To: COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
Reel/Frame 069594/0188 →
Assignment of Assignor's Interest
Dec 17, 2024
From: COSUD INTELLECTUAL PROPERTY SOLUTIONS, P.C.
To: DMA PATENT PARTNERS
Reel/Frame 069611/0047 →
Merger and Change of Name
Oct 20, 2025
From: APHAIA IP AG; APHAIA IP AG
To: APHAIA PHARMA AG
Reel/Frame 072608/0036 →